MTB
60
-7
CTAS
52
-4
DG
42
-2
ROP
45
-8
BAC
50
-3
SWKS
46
-4
KMX
46
-12
HON
58
-7
AIG
54
-5
MO
53
-3
AIV
47
-3
ADI
59
-4
ROK
56
-4
BLK
57
-4
R
63
-2
WMB
58
-2
FRT
41
-5
CTSH
45
-6
CCL
57
-8
QCOM
59
-3
MTB
60
-7
CTAS
52
-4
DG
42
-2
ROP
45
-8
BAC
50
-3
SWKS
46
-4
KMX
46
-12
HON
58
-7
AIG
54
-5
MO
53
-3
AIV
47
-3
ADI
59
-4
ROK
56
-4
BLK
57
-4
R
63
-2
WMB
58
-2
FRT
41
-5
CTSH
45
-6
CCL
57
-8
QCOM
59
-3
Financhill
Back

iShares JPX-Nikkei 400 ETF Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
50

JPXN
iShares JPX-Nikkei 400 ETF

Last Price:
$78.8000
Seasonality Move:
0.19%
Sell
42

APLS
Apellis Pharmaceuticals

Last Price:
$18.84
Seasonality Move:
-0.62%
Sell
50
iShares JPX-Nikkei 400 ETF (JPXN) is a Sell

Is iShares JPX-Nikkei 400 ETF a Buy, Sell or Hold?

  • The current iShares JPX-Nikkei 400 ETF [JPXN] share price is $78.6073. The Score for JPXN is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • JPXN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $18.83. The Score for APLS is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

JPXN Stock Price Chart

What is iShares JPX-Nikkei 400 ETF's stock price today?

  • The iShares JPX-Nikkei 400 ETF share price today is $78.6073
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JPXN is experiencing slight selling pressure.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $18.83
    The current trend is relatively stagnant and APLS is experiencing slight selling pressure.

JPXN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 21.87 Buy
Relative Strength Index (14 RSI): 54.96 Buy
Chaikin Money Flow: -393 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (77.1629 - 79.1629) Buy
Bollinger Bands (100): (71.5465 - 77.4665) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.19 Buy
Relative Strength Index (14 RSI): 51.68 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.04 - 19.02) Buy
Bollinger Bands (100): (18.02 - 27.22) Sell

JPXN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 78.77 Sell
20-day SMA: 78.5 Buy
50-day SMA: 75.68 Buy
200-day SMA: 73.99 Buy
8-day EMA: 68.24 Buy
20-day EMA: 43.41 Buy
50-day EMA: 21.58 Buy
200-day EMA: 6.06 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 19.15 Sell
20-day SMA: 18.27 Buy
50-day SMA: 18.45 Buy
200-day SMA: 27.26 Sell
8-day EMA: 19 Sell
20-day EMA: 18.61 Buy
50-day EMA: 19.47 Sell
200-day EMA: 27.34 Sell

iShares JPX-Nikkei 400 ETF Earnings Growth & JPXN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.18 per share, a decrease this year of $0.14 per share, and an increase next year of $1.12 per share.

iShares JPX-Nikkei 400 ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):